VREOF announces 1-for-30 reverse split for 2026-06-05Vireo Growth Inc.（VREOF）宣布 1:30 合股，生效日 2026-06-05

Corporate Action Details

Vireo Growth Inc. (ticker: VREOF) completed a 1-for-30 reverse stock split on June 5, 2026, an action formally disclosed via a Form 8-K filed with the U.S. Securities and Exchange Commission on May 29, 2026. This structural capital adjustment does not alter the company’s intrinsic value, and market participants should monitor impacts to share price tiers, outstanding share count, and related derivative contracts.

Mechanical Effects

The reverse split consolidates 30 issued and outstanding common shares into one new share, with a proportional inverse adjustment to the per-share price while total market capitalization remains unchanged. For context, VREOF closed at approximately $12.58 per share ahead of the split, implying a theoretical post-split per-share price of roughly $377.28, with total outstanding shares reduced to 1/30 of their pre-split count.

Signal Interpretation

For VREOF, a cannabis specialty drug manufacturer operating in the U.S. medical and adult-use cannabis space, this 1-for-30 reverse split likely serves to maintain U.S. exchange listing compliance. Most major U.S. stock exchanges require a minimum $1 per share price to avoid delisting, and the company’s prior sustained low share price may have prompted this capital structure adjustment.

What to Watch Next

This split alone does not signal improved company fundamentals, nor does it guarantee future revenue, earnings, or operational growth. Investors should monitor upcoming SEC filings for post-split outstanding share data, as well as any concurrent capital or operational announcements from the firm.